ActiveRADAR in the News

University of California, Berkeley, Study Confirms Efficacy of Prescription Drug Reference Pricing for Lowering Drug Costs for Employers and Patients Using ActiveRADAR’s Solution, Study Featured in JAMA Builds on Previous Research to Demonstrate Power of Reference Pricing to Decrease Prescription Drug Costs over Two and a Half- and Five-Year Time Frames Sacramento, CA – February…

ActiveRADAR Reference Pricing can help lower Pharmacy Drug Spend

Using proprietary technology, ActiveRADAR identifies the lowest cost prescription options. Options that are clinically correct and therapeutically equivalent to Brand and Generic drug alternatives. We help plan members transition to lower cost, therapeutic equivalents, delivering immediate savings to them and their plan sponsors. ActiveRADAR is addressing the pricing issue head on, going well beyond standard…